In 2008 a $15,000 grant was awarded to Dr. Betina Lew of the University of Rochester, who is looking at the “In utero” exposure to TCDD and the development of breast cancer. TCDD activates the AhR receptor which can lead to later life breast cancer. So if the AhR receptor can be deregulated, perhaps cancer formation in later life can be prevented.